Long-Term Hypermethylation of FcγR2B in Leukocytes of Patients with Kawasaki Disease
Open Access
- 27 May 2021
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (11) , 2347
Abstract
The Fc gamma receptor family contains several activating receptors and the only inhibitory receptor, FcγR2B. In this study, we investigated the dynamic methylation change of FcγR2B in different stages of Kawasaki disease (KD). We enrolled a total of 116 participants, which included patients with febrile diseases as controls and KD patients. Whole blood cells of KD patients were collected prior to intravenous immunoglobulin (IVIG) treatment (KD1), three to seven days after IVIG (KD2), three weeks after IVIG treatment (KD3), six months after IVIG (KD4), and one year after IVIG treatment (KD5). In total, 76 KD patients provided samples in every stage. Leukocytes of controls were also recruited. We performed DNA extraction and pyrosequencing. FcγR2B methylation levels were higher in KD3 compared to both the controls and KD1. A significantly higher methylation of FcγR2B was found in KD5 when compared with KD1. FcγR2B methylation levels in the IVIG-resistant group were lower than those in the IVIG-responsive group at KD1-3 (p = 0.004, 0.004, 0.005 respectively). This study is the first to report the dynamic change of FcγR2B methylation and to demonstrate long-term hypermethylation one year after disease onset. Hypomethylation of FcγR2B is associated with IVIG resistance.Keywords
Funding Information
- Ministry of Science and Technology, Taiwan (MOST 108-2314-B-182 -037 -MY3)
- Kaohsiung Chang Gung Memorial Hospital (CMRPG8H1161, CMRPG8E0211, CMRPG8J1151, CPRPG8F0791, CMRPG8K0641, CFRPG8K0051, 8K0061, 8K0071, 8K0081)
This publication has 43 references indexed in Scilit:
- Kawasaki disease and subsequent risk of allergic diseases: a population-based matched cohort studyBMC Pediatrics, 2013
- Epigenetic modifications and improved regulatory T-cell function in subjects undergoing dual sublingual immunotherapyJournal of Allergy and Clinical Immunology, 2012
- Functional FCGR2B gene variants influence intravenous immunoglobulin response in patients with Kawasaki diseaseJournal of Allergy and Clinical Immunology, 2011
- Intravenous gammaglobulin suppresses inflammation through a novel TH2 pathwayNature, 2011
- FcγRIIB in autoimmunity and infection: evolutionary and therapeutic implicationsNature Reviews Immunology, 2010
- Fcγ receptors: structure, function and role as genetic risk factors in SLEGenes & Immunity, 2009
- Intravenous immunoglobulin does not increase Fc RIIB expression on monocytes/macrophages during acute Kawasaki diseaseRheumatology, 2004
- Diagnosis, Treatment, and Long-Term Management of Kawasaki DiseaseCirculation, 2004
- Two Distinct Regions of the Mouse β FcγR Gene Control Its TranscriptionImmunobiology, 1992
- Mononuclear cell subsets and coronary artery lesions in Kawasaki disease.Archives of Disease in Childhood, 1992